These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14637115)

  • 1. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury.
    Gonzalez R; Glaser J; Liu MT; Lane TE; Keirstead HS
    Exp Neurol; 2003 Nov; 184(1):456-63. PubMed ID: 14637115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.
    Gonzalez R; Hickey MJ; Espinosa JM; Nistor G; Lane TE; Keirstead HS
    Regen Med; 2007 Sep; 2(5):771-83. PubMed ID: 17907930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of the chemokine CXCL10 reduces apoptosis and increases axon sprouting after spinal cord injury.
    Glaser J; Gonzalez R; Sadr E; Keirstead HS
    J Neurosci Res; 2006 Sep; 84(4):724-34. PubMed ID: 16862543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine antagonist infusion promotes axonal sparing after spinal cord contusion injury in rat.
    Ghirnikar RS; Lee YL; Eng LF
    J Neurosci Res; 2001 Jun; 64(6):582-9. PubMed ID: 11398181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of the chemokine CXCL10 enhances tissue sparing and angiogenesis following spinal cord injury.
    Glaser J; Gonzalez R; Perreau VM; Cotman CW; Keirstead HS
    J Neurosci Res; 2004 Sep; 77(5):701-8. PubMed ID: 15352216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury.
    Jones TB; Hart RP; Popovich PG
    J Neurosci; 2005 Jul; 25(28):6576-83. PubMed ID: 16014718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
    Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
    Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment.
    Hu J; Yang Z; Li X; Lu H
    J Neuroinflammation; 2016 Jun; 13(1):162. PubMed ID: 27334337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury.
    Lutton C; Young YW; Williams R; Meedeniya AC; Mackay-Sim A; Goss B
    J Neurotrauma; 2012 Mar; 29(5):957-70. PubMed ID: 21568693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic influences on cellular reactions to spinal cord injury: a wound-healing response present in normal mice is impaired in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration.
    Zhang Z; Fujiki M; Guth L; Steward O
    J Comp Neurol; 1996 Jul; 371(3):485-95. PubMed ID: 8842901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranylacetone limits secondary injury, neuronal death, and progressive necrosis and cavitation after spinal cord injury.
    Fujiki M; Furukawa Y; Kobayashi H; Abe T; Ishii K; Uchida S; Kamida T
    Brain Res; 2005 Aug; 1053(1-2):175-84. PubMed ID: 16054120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
    Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
    J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary degeneration reduced by inosine after spinal cord injury in rats.
    Liu F; You SW; Yao LP; Liu HL; Jiao XY; Shi M; Zhao QB; Ju G
    Spinal Cord; 2006 Jul; 44(7):421-6. PubMed ID: 16317421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
    Liu MT; Keirstead HS; Lane TE
    J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury.
    Popovich PG; Guan Z; Wei P; Huitinga I; van Rooijen N; Stokes BT
    Exp Neurol; 1999 Aug; 158(2):351-65. PubMed ID: 10415142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury.
    Widenfalk J; Lipson A; Jubran M; Hofstetter C; Ebendal T; Cao Y; Olson L
    Neuroscience; 2003; 120(4):951-60. PubMed ID: 12927201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.
    Cheng X; Zheng Y; Bu P; Qi X; Fan C; Li F; Kim DH; Cao Q
    Exp Neurol; 2018 Jan; 299(Pt A):97-108. PubMed ID: 29056364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry.
    Stirling DP; Yong VW
    J Neurosci Res; 2008 Jul; 86(9):1944-58. PubMed ID: 18438914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration.
    Zhang Z; Guth L
    Exp Neurol; 1997 Sep; 147(1):159-71. PubMed ID: 9294413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.